Search clinical trials for: Tefinostat
Total 60 results
-
Queen Mary University of LondonChroma TherapeuticsUnknownHepatocellular CarcinomaUnited Kingdom
-
Oxford BioMedicaActive, not recruitingAge-Related Macular DegenerationUnited States
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
OnxeoTerminatedNon-Hodgkin's Lymphoma | Cutaneous T-Cell Lymphoma | Peripheral T-Cell LymphomaUnited States, Germany, Israel, France, Thailand
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell LymphomaUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Singapore
-
National Cancer Institute (NCI)CompletedThymic Carcinoma | ThymomaUnited States
-
OnxeoSpectrum Pharmaceuticals, IncCompletedLymphoma | Solid TumorUnited States, Denmark, United Kingdom
-
Herlev HospitalRoche Pharma AG; Bispebjerg Hospital; Copenhagen University Hospital at Herlev; Onxe...TerminatedNon Small Cell Lung CancerDenmark
-
OnxeoSpectrum Pharmaceuticals, IncCompletedCarcinoma of Unknown PrimaryUnited States, Germany, France, Denmark
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Oxford BioMedicaCompletedAge Related Macular DegenerationUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Primary Peritoneal Cavity Cancer | Brenner Tumor | Recurrent Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma | Ovarian Mixed Epithelial Carcinoma | Ovarian...United States
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
OnxeoCompletedOvarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Epithelial Ovarian CancerUnited States, Denmark, United Kingdom
-
Acrotech Biopharma Inc.OnxeoCompletedStage IV Non-small Cell Lung CancerUnited States
-
OnxeoSpectrum Pharmaceuticals, IncCompletedDose Escalation: Solid Tumors | MTD: Soft Tissue SarcomasDenmark, United Kingdom
-
Spectrum Pharmaceuticals, IncOnxeoCompletedPeripheral T-cell LymphomaUnited States, Belgium, United Kingdom, Germany, Spain, Poland, Israel, Netherlands, Canada, Croatia, Denmark, France, Hungary, Italy, Russian Federation, Slovakia, South Africa
-
OnxeoCompleted
-
Acrotech Biopharma Inc.Completed
-
University of UtahNovartis; Acrotech BiopharmaRecruitingMetastatic Breast Cancer | Recurrent Ovarian CarcinomaUnited States
-
OnxeoTerminatedMultiple MyelomaUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedTerminatedRelapsed/Refractory Solid Tumors/Hematological MalignanciesUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedNeoplasms | LymphomasUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizer; Acrotech Biopharma Inc.RecruitingMetastatic Uveal MelanomaUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
University of Michigan Rogel Cancer CenterPfizer; Acrotech Biopharma Inc.RecruitingMetastatic Breast Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Ovarian CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
Holy Cross Hospital, FloridaTerminatedNon-Small-Cell Lung CarcinomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingCarcinoma, Neuroendocrine | Tumor, Neuroendocrine | Tumors, Neuroendocrine | Neuroendocrine; Carcinoma | Small Cell; ReceptorsUnited States
-
University of UtahBristol-Myers Squibb; Acrotech Biopharma Inc.Withdrawn
-
OnxeoCompletedAcute Myeloid LeukemiaUnited Kingdom, Germany, France
-
National Cancer Institute (NCI)CompletedSmall Cell Lung Carcinoma | Malignant Epithelial Neoplasms | Carcinoma NeuroendocrineUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Emory UniversityJohns Hopkins University; National Cancer Institute (NCI); National Institute... and other collaboratorsActive, not recruitingGlioblastoma Multiforme of BrainUnited States
-
National Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1... and other conditionsUnited States
-
University of VirginiaCelgeneRecruiting
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, Belgium, Latvia, Lithuania, Japan
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumor | Hematological MalignanciesUnited States
-
Psychiatric University Hospital, ZurichCompleted
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway